AlphaMed is a small business headquartered in Massachusetts. The primary focus of the company is to develop and supply scarce radioisotopes for use in conjunction with therapeutic radiopharmaceuticals.
AlphaMed is taking orders for the following isotopes: (see products for delivery info)
- Radium - 224/Lead-212/Bismuth-212
- Actinium - 225/Bismuth-213
- Indium - 111
- Lutetium - 177
- Iodine - 123
- Copper - 67
- Scandium - 47
Yttrium – 90 AlphaMed has on-going research and is seeking venture partners to develop low-cost, high purity Y-90
AlphaMed News: •AlphaMed shipped its first Ra-224 generators from its contracted facilities at Pacific Northwest National Laboratory in Richland, Washington in early December. The next production run is being scheduled for the end of January. •The Amercian Chemical Society has accepted AlphaMed's paper titled "Photonuclear Production of In-111". AlphaMed's Herbert Moore will present the paper at the Symposium on Development of High LET Therapeutic Radiopharmaceuticals. The symposium will be held during the Spring 2003 National ACS Meeting being held on March 23 to 27 in New Orleans, LA.
